TABLE 3.
Distribution of drug susceptibility in groups of patients infected with strains of different evolutionary lineages
| Drug susceptibility | No. (%)a of isolates grouped by evolutionary lineage |
||
|---|---|---|---|
| Beijing (n = 86) | Non-Beijing (n = 78) | Both (n = 21) | |
| Pansusceptible | 61 (70.9) | 62 (79.5) | 15 (71.4) |
| Non-MDR | 10 (11.6) | 13 (16.7) | 5 (23.8) |
| MDR | 15 (17.4) | 3 (3.8) | 1 (4.8) |
The percentage in parentheses represents the number of isolates divided by the total number of isolates within each group.